The last mile of care isn’t where the work ends — it’s where value begins. The most advanced analytics mean nothing if they can’t be activated by the people delivering care. The post The Last Mile of Care: Why Value-Based Success Starts at the Bedside appeared first on MedCity News.
Join industry leaders to explore how advanced technologies like RFID, AI, EMR, and ERP systems are transforming hospitals into connected ecosystems that enhance efficiency, streamline workflows, and improve patient outcomes.
Galapagos and Gilead Sciences have both evolved since inking their R&D collaboration agreement in 2019. Separating Galapagos into two offers a way for that company to pursue its cell therapy strategy while also keeping the Gilead alliance alive, executives from both companies said. The post Galapagos CEO Tells JPM Audience the Rationale for Planned Business…
The FDA has eliminated a safety monitoring requirement and eased certain restrictions that had been in place since CAR T-therapies first reached the market in 2017. The agency and financial analysts say the changes should improve patient access to these personalized cancer treatments. The post FDA Just Made Key Some Key Regulatory Changes to Make…
Republicans in Congress have suggested big cuts to Medicaid. But what exactly is it? Medicaid, the state-federal health insurance program for people with low incomes or disabilities, is integral to the U.S. health care system. It keeps hospitals and other providers afloat, provides a key source of federal funds to states, and helps provide health…
SACRAMENTO, Calif. — California has halted a court-ordered medical parole program, opting instead to send its most incapacitated prisoners back to state lockups or release them early. The unilateral termination is drawing protests from attorneys representing prisoners and the author of the state’s medical parole legislation, who say it unnecessarily puts this vulnerable population at…
Consumers First opposes the proposed removal of quality measures that focus on health equity
Pharvaris’s deucrictibant met the main and secondary goals of its Phase 3 test as an on-demand treatment for swelling attacks caused by the rare disease hereditary angioedema. Pharvaris’s capsule could compete against Kalvista Pharmaceuticals’ Ekterly, an HAE pill approved by the FDA over the summer. The post Pharvaris Drug for Rare Swelling Disease Meets Phase…
A look at some of the top law firms that serve companies in the healthcare and life sciences fields, from early stage startups to growth stage businesses. The post The Go-To Law Firms For Healthcare and Life Sciences appeared first on MedCity News.
Nearly all CIOs and other healthcare technology leaders at provider organizations believe that effectively leveraging AI gives them a competitive edge, according to new research. However, the report also found that some organizations still struggle with barriers to adoption, such as the lack of the right talent and concerns about ethics, privacy and security. The…